Centro de Estudos de Doenças Crónicas (CEDOC)

2022

L2A5 antibody or functional fragment thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 26 Jan 2022, Patent No. ZA202005023, 24 Aug 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

2021

L2A5 Antibody or functional fragment thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M., 4 Feb 2021, IPC No. G01N 33/ 574 A I, Patent No. US2021033616, 24 Jul 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

抗肿瘤抗原的L2A5抗体或其功能性片段

Translated title of the contribution: L2A5 ANTIBODY OR FUNCTIONAL FRAGMENT THEREOF AGAINST TUMOUR ANTIGENSVideira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., LIma, L. C. O., Chai, W. & Bachmann, M. P., 20 Aug 2021, IPC No. G01N 33/ 574 A I, Patent No. CN113287018, 25 Sept 2020, Priority date 17 Jan 2019, Priority No. WO2019PT00001

Research output: Patent › Regional/Other National Application

腫瘍抗原に対するＬ２Ａ５抗体またはその機能的断片

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 1 Jul 2021, IPC No. G01N 33/ 574 A I, Patent No. JP2021516254, 21 Jul 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

종양 항원에 대한 L2A5 항체, 그것의 기능적 단편 또는 그것의 프로브

Translated title of the contribution: L2A5 antibody or functional fragment thereof against tumour antigensVideira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 14 Jan 2021, IPC No. G01N 33/ 574 A I, Patent No. KR20210005546, 28 Jun 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

2020

Anticorpo, fragmento funcional ou sonda do mesmo contra antígenos tumorais

Videira, P. A. Q., Novo, C. M. M., Ferreira, J. A. R. D. C., Loureiro, L. R. R., Lima, L. C. O., Santos, L. L., Palma, M. A. D. S., Michael, B., Wengang, C. & Carrascal, M. A. D. R., 8 Dec 2020, IPC No. G01N 33/ 574 A I, Patent No. BR112020014931, 20 Oct 2020, Priority date 17 Jan 2019, Priority No. WO2019PT00001

Research output: Patent › Regional/Other National Application

L2A5 antibody or functional fragment thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M., 6 Aug 2020, IPC No. G01N 33/ 574 A I, Patent No. AU2019211035, 28 Jun 2020, Priority date 17 Jan 2019, Priority No. WO2019PT00001

Research output: Patent › Regional/Other National Application

L2A5 Antibody or functional fragment thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 28 Aug 2020, IPC No. G01N 33/ 574 A I, Patent No. SG11202006897V, 20 Jul 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

L2A5 Antibody or functional fragment thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 2 Dec 2020, IPC No. G01N 33/ 574 A I, Patent No. EP3743726, 26 Aug 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

АНТИТЕЛО, ЕГО ФУНКЦИОНАЛЬНЫЙ ФРАГМЕНТ ИЛИ ЗОНД ПРОТИВ ОПУХОЛЕВЫХ АНТИГЕНОВ

Translated title of the contribution: L2A5 ANTIBODY OR FUNCTIONAL FRAGMENT THEREOF AGAINST TUMOUR ANTIGENSVideira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M. P., 23 Nov 2020, IPC No. G01N 33/ 574 A I, Patent No. EA202091760, 20 Aug 2020, Priority date 26 Jan 2018, Priority No. PT11052618A

Research output: Patent › Regional/Other National Application

2019

Antibody, functional fragment or probe thereof against tumour antigens

Videira, P. A. Q., Novo, C. M. M., Loureiro, L. R. R., Carrascal, M. A. D. R., Ferreira, J. A. R. D. C., Palma, M. A. D. S., Santos, L. L., Lima, L. C. O., Chai, W. & Bachmann, M., 1 Aug 2019, IPC No. G01N 33/ 574 A I, Patent No. CA3089300, Priority date 17 Jan 2019, Priority No. WO2019PT00001

Research output: Patent › Regional/Other National Application

2018

A viable cell population, method for production and uses thereof

Matos, M. T. D. J., Videira, P. A. Q., Da Silva, M. A. A. M., Costa De Carvalho Marques, G. S., Ferro, T. J. S. F., Da Silva, Z. M. C., Monteiro, M. A. D. B., Gonçalves, M. F., Tadokoro, C. E., Van Kooyk, Y. & Van Vliet, S. J., 9 May 2018, IPC No. C12N 5/ 0784 A I, A61K35/15, Patent No. EP3317402, 30 Jan 2018, Priority date 29 Jun 2016, Priority No. WO2016IB53901

Research output: Patent › Regional/Other National Application

Centro de Estudos de Doenças Crónicas (CEDOC)

Research output

Search results